Search - tctmd.com

Displaying 521 - 540 of 638

Sort: Relevancy | Date

Presentation ECHO 2015

3-D Echocardiography for Valvular Heart Disease

Presenter: Rebecca T. Hahn

April 27, 2015

Presentation ECHO 2015

Pitfalls in valvular heart disease assessment

Presenter: Omar Khalique

April 26, 2015

Presentation CATCH-UP 2015

Heart Failure Cardiologist Perspective on Valvular Heart Disease: Focus on Severe AS and Functional MR

Presenter: Melana Yuzefpolskaya

April 25, 2015

News Daily News

人类首例经导管三尖瓣修复证明可行

April 03, 2015

News Daily News

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

April 03, 2015

News Daily News

Reparación Transcatéter de la Válvula Tricúspide Viable en el 1er Caso en Humanos

April 03, 2015

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2014

Caitlin E. Cox

January 12, 2015

News Daily News

Aortic, Mitral Regurgitant Volume May Predict Cardiac Function in Asymptomatic Patients

Yael L. Maxwell

December 10, 2014

News Daily News

In-Hospital STEMI Deadlier, More Expensive Than Out-of-Hospital STEMI

November 19, 2014

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Daily News

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

Yael L. Maxwell

October 24, 2014

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

Presentation TCT 2014

MitraClip: Current Application and Future Directions

Presenter: Blase A. Carabello, George D. Dangas, Michael J. Rinaldi

September 15, 2014

Presentation TCT 2014

Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD)

Presenter: Blase A. Carabello, George D. Dangas

September 15, 2014

Presentation TCT 2014

TAVR On the Horizon: Emerging TAVR Platforms and Technologies

Presenter: Blase A. Carabello, George D. Dangas, Lutz Buellesfeld

September 15, 2014

Presentation TCT 2014

TAVR Update: FDA-Approved Valve Systems

Presenter: Blase A. Carabello, George D. Dangas, Alan C. Yeung

September 15, 2014

Presentation TCT 2014

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

Presenter: Blase A. Carabello, George D. Dangas, Patrick T. O'Gara

September 15, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

Presentation TCT 2014

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Zoltan G. Turi, Jason Kovacic

September 14, 2014

Presentation TCT 2014

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Hemal Gada

September 14, 2014

Advertisement

3-D Echocardiography for Valvular Heart Disease

Pitfalls in valvular heart disease assessment

Heart Failure Cardiologist Perspective on Valvular Heart Disease: Focus on Severe AS and Functional MR

人类首例经导管三尖瓣修复证明可行

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

Reparación Transcatéter de la Válvula Tricúspide Viable en el 1er Caso en Humanos

TCTMD’s Top 10 Most Popular News Stories for 2014

Aortic, Mitral Regurgitant Volume May Predict Cardiac Function in Asymptomatic Patients

In-Hospital STEMI Deadlier, More Expensive Than Out-of-Hospital STEMI

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

MitraClip: Current Application and Future Directions

Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD)

TAVR On the Horizon: Emerging TAVR Platforms and Technologies

TAVR Update: FDA-Approved Valve Systems

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content